CHC Healthcare Group (TPE:4164) Ending Cash Position: NT$1,367 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4164 CHC Healthcare Group TPE:4164
78 GF Score
Price NT$26.20
GF Value NT$49.14
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is CHC Healthcare Group Ending Cash Position?

CHC Healthcare Group TPE:4164 -0.38% 78 Ending Cash Position is NT$1,367 Mil as of Jun. 2026. GuruFocus rates TPE:4164 with a GF Score™ of 78/100 and a GF Value™ of NT$49.14 (Possible Value Trap). The stock has 8 warning signs investors should review.

CHC Healthcare Group's Ending Cash Position for the quarter that ended in Jun. 2026 was NT$1,367 Mil.

CHC Healthcare Group's quarterly Ending Cash Position declined from Dec. 2025 (NT$1,786 Mil) to Mar. 2026 (NT$1,575 Mil) and declined from Mar. 2026 (NT$1,575 Mil) to Jun. 2026 (NT$1,367 Mil).

CHC Healthcare Group's annual Ending Cash Position declined from Dec. 2023 (NT$1,891 Mil) to Dec. 2024 (NT$1,642 Mil) but then increased from Dec. 2024 (NT$1,642 Mil) to Dec. 2025 (NT$1,786 Mil).


CHC Healthcare Group Ending Cash Position Related Terms


CHC Healthcare Group Ending Cash Position Historical Data

* Premium members only.

The historical data trend for CHC Healthcare Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CHC Healthcare Group Ending Cash Position Chart

CHC Healthcare Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,493.93 1,472.85 1,891.38 1,641.78 1,786.49

CHC Healthcare Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,059.80 1,415.58 1,786.49 1,575.00 1,367.42
TPE:4164
78GF Score
CHC Healthcare Group TPE:4164
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CHC Healthcare Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

CHC Healthcare Group's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1641.783+144.71
=1,786

CHC Healthcare Group's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1574.999+-207.576
=1,367

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of NT$1,367 Mil mean?
CHC Healthcare Group (TPE:4164) has a Ending Cash Position of NT$1,367 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on CHC Healthcare Group and its competitors.
Is CHC Healthcare Group's Ending Cash Position too high?
CHC Healthcare Group's current Ending Cash Position is NT$1,367 Mil. Overall, CHC Healthcare Group has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CHC Healthcare Group's Ending Cash Position compare to MCK and COR?
CHC Healthcare Group's Ending Cash Position of NT$1,367 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Distribution company?
A good Ending Cash Position depends on the Medical Distribution industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on CHC Healthcare Group and its competitors. CHC Healthcare Group's current Ending Cash Position is NT$1,367 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CHC Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, CHC Healthcare Group (TPE:4164) is currently considered Possible Value Trap. The stock's GF Value™ is NT$49.14, compared to a current price of NT$26.20 — trading 46.7% below its estimated fair value. The current Ending Cash Position is NT$1,367 Mil. CHC Healthcare Group's overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For CHC Healthcare Group (TPE:4164), the current Ending Cash Position is NT$1,367 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CHC Healthcare Group (TPE:4164) Overvalued in 2026?

Based on GuruFocus' analysis, CHC Healthcare Group stock appears to be undervalued. The current stock price of NT$26.20 is trading 46.7% below its estimated GF Value™ of NT$49.14. GuruFocus considers CHC Healthcare Group to be Possible Value Trap.

Key valuation signals for TPE:4164:

  • Ending Cash Position: NT$1,367 Mil
  • GF Value™: NT$49.14 vs. price of NT$26.20 (46.7% below fair value)
  • GF Score™: 78/100 with 8 warning signs

No single metric tells the full story. See the TPE:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CHC Healthcare Group Business Description

Address No. 88, Xing’ai Road, Neihu District, Taipei, TWN, 114067
CHC Healthcare Group is a Taiwan-based company engaged in the trading of pharmaceutical products and health food, as well as the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment used in radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, the sale of medical instruments, repairs, maintenance, and other services.
78GF Score

Get the complete analysis for TPE:4164

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$26.20
Price
NT$49.14
GF Value